-       Report 
- September 2022
-  181 Pages 
- Asia Pacific 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- September 2022
-  127 Pages 
- North America 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- August 2022
-  104 Pages 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- August 2022
-  112 Pages 
- Middle East, Africa 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- August 2022
-  124 Pages 
- Asia Pacific 
   From       €3070EUR$3,450USD£2,702GBP 
           -       Report 
- July 2022
-  120 Pages 
- North America 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- July 2022
-  132 Pages 
- Europe 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- July 2022
-  122 Pages 
- United Kingdom 
   From       €3070EUR$3,450USD£2,702GBP 
          -       Report 
- March 2022
-  198 Pages 
- Global 
   From       €3960EUR$4,450USD£3,486GBP 
          -       Report 
- February 2022
-  174 Pages 
- Global 
   From       €3960EUR$4,450USD£3,486GBP 
          -       Report 
- August 2024
-  135 Pages 
- Global 
   From       €3515EUR$3,950USD£3,094GBP 
          -       Report 
- August 2024
-  110 Pages 
- Global 
   From       €3515EUR$3,950USD£3,094GBP 
          -       Report 
- May 2024
-  130 Pages 
- Global 
   From       €3515EUR$3,950USD£3,094GBP 
          -       Report 
- April 2024
-  121 Pages 
- Global 
   From       €3515EUR$3,950USD£3,094GBP 
          -       Report 
- April 2024
-  120 Pages 
- Global 
   From       €3782EUR$4,250USD£3,329GBP 
          -       Report 
- November 2023
-  146 Pages 
- Global 
   From       €3960EUR$4,450USD£3,486GBP 
          -       Report 
- January 2023
-  132 Pages 
- Global 
   From       €3960EUR$4,450USD£3,486GBP 
          -       Report 
- December 2022
-  142 Pages 
- Global 
   From       €3960EUR$4,450USD£3,486GBP 
          -       Report 
- December 2019
-  120 Pages 
- Global 
   From       €3292EUR$3,700USD£2,898GBP 
          -       Report 
- July 2025
-  200 Pages 
- India 
   From       €2482EUR$2,789USD£2,185GBP 
       
       The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically    more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less   Read more